Overture Life Secures $57M in Total Funding and Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Summary
They also pave the way for the launch of DaVitri, an advanced embryology platform that automates egg freezing (vitrification) and embryo warming under reproducible, data-driven protocols.For too long, IVF has been inaccessible for too many people, with inefficiencies driving up costs. By standardizing these procedures with precise timing and controlled cryoprotectant exposure, DaVitri has demonstrated improved oocyte survival rates in early clinical evaluations, potentially reducing repeated IVF cycles that can drain resources and emotional energy. DaVitri has already shown potential to significantly increase clinical throughput while ensuring reproducibility in critical freezing and warming processes, allowing embryologists to prioritize personalized patient care. It allows us to deliver consistent and excellent care, while still giving us the flexibility to fine-tune protocols for our patients," said Serena H. Chen, MD, a Reproductive Endocrinologist at CCRM Fertility of NJ. By fitting the embryology protocols into a compact, desk-sized system, Overture is reinventing egg freezing and IVF for a better patient experience and strong, clinically reproducible outcomes with proven science.Overture Life integrates engineering, reproductive medicine, and regulatory-grade validation to modernize embryology lab procedures, particularly egg freezing and embryo handling, in ways that lower repeated cycles, increase throughput, and reduce the overall cost of IVF.